- Recent Funding
- Investors
- Solve FSHD
Solve FSHD portfolio
Solve FSHD has 2 portfolio companies on record at Recent Funding.
About this page
Its most recent investment on record is Epicrispr Biotechnologies's $68M Series B+ round in March 2025, alongside Ally Bridge Group. By category, its portfolio leans toward Health and bio (2).
What Solve FSHD invests in
- Health and bio · 2 · 100%
How Solve FSHD invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $68M |
Solve FSHD portfolio companies
EEpicrispr Biotechnologies$68MSeries B+ · Mar 2025
AAltay Therapeuticsbacker
| Company | Round with Solve FSHD | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $68M | $158M | Aug 11, 2026 Series B+ |
Health and bio |
backer | undisclosed | — |
Most frequent co-investors
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Solve FSHD. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Solve FSHD, which is a subset of its real portfolio. API: /api/v1/investors/solve-fshd (get a free API key). More: the most active VC firms and new venture capital funds.